Epirubicin in advanced gastrointestinal (GI) cancer
نویسندگان
چکیده
منابع مشابه
Gastrointestinal (GI) Disorders in Pregnancy
یکی از شکایات شایع دوران حاملگی، اختلالات معده ای روده ای (GI) است. اطلاع از میزان بروز و چگونگی اختلالات معده ای روده ای، نوع مراقبت از بیماران حامله را تعیین خواهد کرد. در این مقاله تغییرات فیزیولوژیک، بیماریهای عفونی، بیماریهای اتوایمون و تشکیل زخم در سیستم گوارشی دوران بارداری مورد بحث قرار گرفته است. هم چنین در مورد درمان و اثرات آنها روی جنین و نیز اثر حاملگی روی انواع اختلالات معدی روده...
متن کاملDocetaxel and epirubicin in advanced breast cancer.
In an International Breast Cancer Study Group phase I/II program, 70 patients with advanced breast cancer received up to eight courses of 75 mg/m2 docetaxel combined with 90 mg/m(2) epirubicin, every 3 weeks. G-CSF was not administered prophylactically. Grade 4 neutropenia occurred in 88% of cycles that were not supported by G-CSF. However, febrile neutropenia affected only 24% of cycles. It oc...
متن کاملPaclitaxel plus epirubicin in advanced breast cancer.
This phase I-II study aimed to determine the maximum tolerated dose (MTD) of paclitaxel (Taxol), infused over 3 hours, when combined with a fixed dose (90 mg/m2) of epirubicin. Other aims were to investigate the combination's plasma pharmacokinetics, toxicity, and activity in 50 patients with previously untreated metastatic breast cancer, as well as its ability to mobilize peripheral blood stem...
متن کاملChemotherapy for advanced endometrial cancer with carboplatin and epirubicin.
UNLABELLED Endometrial cancer is the most common gynecological cancer in the Western world. In early-stage disease, surgery remains the mainstay of treatment. Adjuvant pelvic radiotherapy reduces the risk of pelvic recurrence, however, without improvement in overall survival. The aim of the present study was to assess the efficacy and toxicity of carboplatin and epirubicin combination chemother...
متن کاملcombination of 5-fu and epirubicin in the treatment of advanced gastric cancer
this study was undertaken to assess the effectiveness of 5-fu plus epirubicin in the treatment of the advanced gastric cancer. for this purpose, 22 patients with no previous treatment were studied. all of the patients were unoperable or metastatic. follow up checking continued for 24 months. our selected therapeutic regimen consisted of a combination of 500 mg/m2 5-fu dialy for five days, and 7...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Cancer Research and Clinical Oncology
سال: 1986
ISSN: 0171-5216,1432-1335
DOI: 10.1007/bf02579924